Discovery of Novel Lead Compounds Against Different DHFR through Pharmacophore Design, Database Mining

Discovery of Novel Lead Compounds Against Different DHFR through Pharmacophore Design, Database Mining (English, Paperback, Dr. Ruchi Mishra)

Share

Discovery of Novel Lead Compounds Against Different DHFR through Pharmacophore Design, Database Mining  (English, Paperback, Dr. Ruchi Mishra)

Be the first to Review this product
₹99
100
1% off
i
Available offers
  • Bank Offer100% Cashback upto 500Rs on Axis Bank SuperMoney Rupay CC UPI transactions on super.money UPI
    T&C
  • Bank Offer5% Unlimited Cashback on Flipkart Axis Bank Credit Card
    T&C
  • Partner OfferBuy Furniture worth more than 30000, get Min. 3000 off!
    Know More
  • Delivery
    Check
    Enter pincode
      Delivery by21 Jun, Saturday|58
      ?
    View Details
    Author
    Read More
    Highlights
    • Language: English
    • Binding: Paperback
    • Publisher: Notion Press
    • Genre: Education
    • ISBN: 9798886674835
    Services
    • Cash on Delivery available
      ?
    Seller
    NotionPress
    3.3
    • 7 Days Replacement Policy
      ?
  • See other sellers
  • Description
    Dihydrofolate reductase (DHFR) catalyzes the reduction of folate or 7,8−dihydrofolate to tetrahydrofolate and intimately couples with thymidylate synthase (TS). This is the exclusive de novo sources of dTMP, hence inhibition of DHFR or TS activity leads to “thymineless death.” Thus, DHFR inhibition has long been an attractive goal for the development of chemotherapeutic agents against bacterial and parasitic infections as well as cancer. Pharmacophore based drug design has been now considered as a powerful approach and has found wide applications in drug design because of the pressing need to reduce the time & cost of candidate drug molecule in discovery phase where the current emphasis is on more rational approaches than trial and error to identify new chemical entities (NCE). In view of this and the urgency to identify new dihyrofolate reductase (DHFR) inhibitors, the main objectives of proposed research endeavor are -  To perform ligand-based drug design (LBDD) and structure based drug design (SBDD).  To use developed pharmacophore for the identification of novel dihydrofolate reductase (DHFR) inhibitors as high affinity ligands against Cancer, Malaria, Pneumocystis crainii Pneumonia (PCP) and Diarrhea.  To create virtual counter screen filters to find high-affinity inhibitor of various DHFRs from drug databases.  To predict the affinity of ligands for the various DHFRs.  To validate the finding of In-silico approach through In-vitro evaluation
    Read More
    Specifications
    Book Details
    Imprint
    • Notion Press
    Dimensions
    Height
    • 8.5 in
    Length
    • 11 in
    Weight
    • 110 gr
    Be the first to ask about this product
    Safe and Secure Payments.Easy returns.100% Authentic products.
    You might be interested in
    Medical And Nursing Books
    Min. 50% Off
    Shop Now
    Language And Linguistic Books
    Min. 50% Off
    Shop Now
    Other Self-Help Books
    Min. 50% Off
    Shop Now
    General Fiction Books
    Min. 50% Off
    Shop Now
    Back to top